EPO receptor modulators (SBI)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameEPO receptor modulators (SBI)
Drug Alias Nameerythropoietin receptor modulators (Structural Bioinformatics)EPO receptor modulators (Structural Bioinformatics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionErythropoietin receptor modulators
TargetsErythropoietin receptor
Therapy Area/IndicationsAnemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCengent Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCengent Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsAnemia

Other Information

ATC CodeN/A
Related LinksN/A